SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XXII Changing the worlds Cigarette market to a safer place!!
XXII 1.530+5.5%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Julius Wong who wrote (6)2/20/2014 6:53:44 AM
From: Time2shine   of 56
 
$XXII conclusion from Seeking Alpha author:

Conclusion


At this point Wall Street doesn't understand 22nd Century Group's potential monopoly on a good part of the reduced risk cigarette market, or the smoking cessation market. Nor do investors yet realize the significance of the British American Tobacco licensing deal and the FDA's anticipation of 22nd Century submitting a modified risk application. 22nd Century is addressing a $700 billion market, and even if the company only achieves 1% penetration, investors would still realize at least a 20X return. From my perspective, the company's profitability, healthy balance sheet and valuable IP portfolio makes this an ideal asymmetrical trade, huge upside potential, with very little downside risk.

http://seekingalpha.com/article/1849101-22nd-century-is-worth-twice-todays-shareprice
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News